Kidney Cancer News and Research

RSS

Kidney cancer is usually defined is a cancer that originates in the kidney. The two most common types of kidney cancer, reflecting their location within the kidney, are renal cell carcinoma (RCC) and urothelial cell carcinoma (UCC) of the renal pelvis.

Recommended amounts of physical activity associated with reduced risk for seven cancers

A pooled analysis of nine prospective studies involving more than 750,000 adults finds that recommended amounts of leisure-time physical activity were linked to a lower risk for seven cancers, with several cancer types having a 'dose/response' relationship.

27 Dec 2019

p53 may play a more important role in kidney cancer than previously thought

The p53 gene, which researchers had thought was less relevant in kidney cancer, may play an important role after all – a discovery that could lead to new treatments.

20 Dec 2019

Jefferson researcher probes kidney cancer's genes for interactions with p53 pathway

p53 is the most famous cancer gene, not least because it's involved in causing over 50% of all cancers. When a cell loses its p53 gene -- when the gene becomes mutated -- it unleashes many processes that lead to the uncontrolled cell growth and refusal to die, which are hallmarks of cancer growth.

20 Dec 2019

Scientists create new classification system for tumors

Based on the largest study of cancer patients of its kind, scientists have created a new way of classifying tumors.

19 Dec 2019

Study opens up new treatment possibilities for Wilms' tumor

As an embryo develops, its cells must learn what to do with the thousands of genes they've been equipped with. That's why each cell comes with a detailed gene-expression manual outlining exactly which genes should be switched on, to what extent, and when.

18 Dec 2019

Experimental drug better for repeat kidney cancer patients than FDA-approved equivalent

Kidney cancer patients who had already tried two or three different treatments had improved chances of preventing cancer progression with an experimental drug called tivozanib compared to an alternative approved by the U.S. Food and Drug Administration, according to a City of Hope-led study.

4 Dec 2019

Simple urine test at home could revolutionize diagnosis of prostate cancer

A simple urine test under development for prostate cancer detection can now use urine samples collected at home - according to new research from University of East Anglia and the Norfolk and Norwich University Hospital.

28 Nov 2019

Pioneering scientist wins 2019 Foulkes Foundation Medal for contributions to biomedical science

Professor Muzlifah Haniffa from Newcastle University and the Wellcome Sanger Institute has won the 2019 Foulkes Foundation Medal for her ground-breaking contributions to biomedical science, it was announced today [Tuesday 19 November, 2019].

18 Nov 2019

Startup seeks to hold doctors, hospitals accountable on patient record requests

When Kelly Shanahan had her OB-GYN practice in South Lake Tahoe, Calif., she was meticulous about providing medical records promptly to all patients who requested them, she said.

18 Nov 2019

Researchers identify new kidney cancer subtypes and clues to better diagnosis, treatment

In what is believed to be the most comprehensive molecular characterization to date of the most common - and often treatment-resistant - form of kidney cancer, researchers at Johns Hopkins' departments of pathology and oncology, Johns Hopkins Kimmel Cancer Center, and the Johns Hopkins University School of Medicine report evidence for at least three distinct subtypes of clear cell renal cell carcinoma (ccRCC), along with new revelations about the proteins that define them.

From Johns Hopkins Medicine 31 Oct 2019

Stratasys to present latest developments in 3D printing at COMPAMED 2019

This year’s COMPAMED (Düsseldorf, 18-21 November) will see 3D printing leader,Stratasys, presenting the latest developments in 3D printing for a range of applications to enhance the design and development of medical devices on its booth (Hall 8b, Stand N02).

From Stratasys 18 Oct 2019

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

Pegilodecakin, a first-in-class drug currently in clinical trials, has shown positive safety results and may offer a potential new treatment avenue for patients with non-small cell lung cancer and kidney cancer.

26 Sep 2019

Investigational drug may offer new treatment option for patients with lung and kidney cancer

26 Sep 2019

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

A metabolic imbalance in some cancer patients following treatment with a checkpoint inhibitor drug, nivolumab, is associated with resistance to the immunotherapy agent and shorter survival, report scientists from Dana-Farber Cancer Institute, in collaborative work with the Broad Institute of MIT and Harvard.

25 Sep 2019

Using 3D virtual reality models to prepare for surgeries improves patient outcomes

A UCLA-led study has found that using three-dimensional virtual reality models to prepare for kidney tumor surgeries resulted in substantial improvements, including shorter operating times, less blood loss during surgery and a shorter stay in the hospital afterward.

19 Sep 2019

Kidney Cancer News and Research

Further Reading

Recommended amounts of physical activity associated with reduced risk for seven cancers

p53 may play a more important role in kidney cancer than previously thought

Jefferson researcher probes kidney cancer's genes for interactions with p53 pathway

Scientists create new classification system for tumors

Study opens up new treatment possibilities for Wilms' tumor

Experimental drug better for repeat kidney cancer patients than FDA-approved equivalent

Simple urine test at home could revolutionize diagnosis of prostate cancer

Pioneering scientist wins 2019 Foulkes Foundation Medal for contributions to biomedical science

Startup seeks to hold doctors, hospitals accountable on patient record requests

Researchers identify new kidney cancer subtypes and clues to better diagnosis, treatment

Stratasys to present latest developments in 3D printing at COMPAMED 2019

Combination therapy may offer new therapeutic avenue for previously-treated NSCLC and kidney cancer patients

Investigational drug may offer new treatment option for patients with lung and kidney cancer

Metabolic imbalance in cancer patients associated with resistance to immune checkpoint blocker

Using 3D virtual reality models to prepare for surgeries improves patient outcomes

Blood sugar levels linked to DNA damage and cancer in diabetics

New discovery could help doctors identify children at risk for Wilms’ tumor relapse

Advanced imaging technology for prostate cancer could increase a man’s chances of survival

Scientists discover novel mechanism of action for NK cells in checkpoint inhibitor for cancer

AI-enabled device detects if targeted chemotherapy is working

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News